OrbiMed Advisors LLC's Form 4 filing
Passage BIO, Inc. (PASG) · filed Apr 17, 2025
- Accession no.
- 0000947871-25-000415
- Filed
- Apr 17, 2025, 6:10 PM ET
- Trade date
- Apr 15-17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $49.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2025 | Common Stock | SSaleDisposed | −10,326 | $0.38 | −$3,923.88 | 7,024,300 | Indirect | |
| Apr 16, 2025 | Common Stock | SSaleDisposed | −61,638 | $0.33 | −$20,340.54 | 6,962,662 | Indirect | |
| Apr 17, 2025 | Common Stock | SSaleDisposed | −77,090 | $0.33 | −$25,439.7 | 6,885,572 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.